Trials show vaccine is safe


Posted on July 1st, by editor in Caring Times. No Comments

Initial results of a clinical trial of a potential vaccine for Alzheimer1s Disease have shown that it is safe and well-tolerated in humans. The World Alzheimer Congress 2000, held in Washington DC in July, heard that animal studies of the vaccine, AN-1792, confirmed that it leads to an immune response which increases the clearance of amyloid plaques from the brain and prevents additional plaques from forming. (Scientists believe that amyloid plaques, found in the brains of most individuals with AD, impede nerve cell function and cause cell death.) The researcher is Dale Schenk from Elan Pharmaceuticals, who said: “Amyloid plaques act as a brain invader. We are optimistic that we can attack this invader at its source and eventually help millions of people and families world wide.”





Comments are closed.


Latest blog posts

It’s a hard, hard world

By Caring Times editor GEOFF HODGSON

A recent survey has found that 63% of the general public believe the NHS provides social care and 42% think...

Sign-up and pay, or perhaps pay more

By Caring Times editor GEOFF HODGSON

There are powerful arguments why carers working at night in small specialist care facilities should be paid their full hourly...

The parallel universes of social care

By guest blogger JOHN BURTON

The Care Quality Commission’s adult social care ‘productivity’ dipped in August and for the umpteenth time the 90% target of...